Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 3 / Research Article
Investigation on Advanced Non-Small-Cell Lung Cancer among Elderly Patients Treated with Chinese Herbal Medicine versus Chemotherapy: A Pooled Analysis of Individual Data Table 3 Hazard ratio estimates based on stratified cox model.
Univariate Analysis Multivariate Analysis HR (95 CI) p-value HR (95 CI) p-value Gender Male 1.00 Female 0.8117 (0.68, 1.) 0.261 Age (continuous) 1.00 (0.99, 1.02) 0.664 Age (categorical) ⩽70 1.00 >70 1.08 (0.86, 1.37) 0.491 Smoking Status Non-smoker 1.00 1.00 Smokers 1.20 (0.96, 1.51) 0.112 1.15 (0.84, 1.46) 0.221 Tumor Location Central Type 1.00 Peripheral Type 1.05 (0.81, 1.36) 0.726 Pathology Non-SQCC 1.00 SQCC 1.09 (0.86, 1.38) 0.467 Stage III 1.00 1.00 IV 1.13 (1.00, 1.28) 0.054 1.11 (0.97,1.26) 0.103 Previous Treatment No 1.00 Yes 1.06 (0.82, 1.37) 0.671 1.03 (0.78, 1.34) 0.853 KPS 60 1.00 1.00 70 0.70 (0.46, 1.07) 0.096 0.74 (0.48, 1.14) 0.168 ⩾ 80 0.36 (0.23, 0.56) <0.001 0.39(0.25, 0.61) <0.001 Treatment Chemotherapy 1.00 1.00 CHM 0.97 (0.87, 1.09) 0.588 0.98 (0.87, 1.10) 0.751
SQCC, squamous cell carcinoma; KPS, Karnofsky performance scores; CHM, Chinese herbal medicine; HR, hazard ratio; CI, confidence intervals.